1. 1039. Rapid Restoration of Bile Acid Compositions After Treatment with RBX2660 for Recurrent Clostridioides difficile Infection—Results from the PUNCH CD3 Phase 3 Trial. (4th December 2021) Authors: Papazyan, Romeo; Fuchs, Bryan; Blount, Ken; Gonzalez, Carlos; Shannon, Bill Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1039. Rapid Restoration of Bile Acid Compositions After Treatment with RBX2660 for Recurrent Clostridioides difficile Infection—Results from the PUNCH CD3 Phase 3 Trial. (4th December 2021) Authors: Papazyan, Romeo; Fuchs, Bryan; Blount, Ken; Gonzalez, Carlos; Shannon, Bill Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 1064. Treatment Success in Reducing Recurrent Clostridioides difficile Infection with Investigational Live Biotherapeutic RBX2660 Is Associated with Microbiota Restoration: Consistent Evidence from a Phase 3 Clinical Trial. (4th December 2021) Authors: Blount, Ken; Walsh, Dana M; Gonzalez, Carlos; Shannon, Bill Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 1064. Treatment Success in Reducing Recurrent Clostridioides difficile Infection with Investigational Live Biotherapeutic RBX2660 Is Associated with Microbiota Restoration: Consistent Evidence from a Phase 3 Clinical Trial. (4th December 2021) Authors: Blount, Ken; Walsh, Dana M; Gonzalez, Carlos; Shannon, Bill Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 129. Antimicrobial Resistance Genes Were Reduced Following Administration of Investigational Microbiota-Based Live Biotherapeutic RBX2660 to Individuals with Recurrent Clostridioides difficile Infection. (4th December 2021) Authors: Hau, Heidi; Walsh, Dana M; Gonzalez, Carlos; Shannon, Bill; Blount, Ken Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 1775. Microbiome-Based Classifiers Accurately Differentiate Infectious Diarrhea From Functional Gastrointestinal Disorders and Provide Population-Scale Confidence Measures of Fecal Microbiota Restoration in Recurrent C. DifficileInfection. (26th November 2018) Authors: Wu, Qinglong; Ross, Cana; Jones, Courtney; Blount, Ken; Savidge, Tor Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 1950. Prevention of Recurrent Clostridium difficile at Six Months Following Treatment With Microbiota-Based Therapy RBX2660: Durability Results From a Phase 2 Open-Label Study. (26th November 2018) Authors: Mische, Sarah; Orenstein, Robert; Dubberke, Erik R; Khanna, Sahil; Hecht, Gail; Dupont, Herbert; Lee, Christine; Blount, Ken Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 1966. Evaluating a Prototype Microbiome Health Index (MHI) as a Measure of Microbiome Restoration Using Data Derived From a Published Study of Fecal Microbiota Transplant (FMT) to Treat Recurrent Clostridium difficile Infections (rCDI). (26th November 2018) Authors: Blount, Ken; Jones, Courtney; Deych, Elena; Shannon, Bill Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S570 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 29. Rapid Restoration of Bile Acid Compositions After Treatment with Investigational Microbiota-based Therapeutic RBX2660 for Recurrent clostrioides Difficile Infection. (31st December 2020) Authors: Ferdyan, Nicky; Papazyan, Romeo; Walsh, Dana; Klein, Sarah; Qi, Steve; Blount, Ken; Srinivasan, Karthik; Fuchs, Bryan Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 30. Antimicrobial Resistance Genes Are Reduced Following Administration of Investigational Microbiota-based Therapeutic RBX7455 to Individuals with Recurrent clostrioides Difficile Infection. (31st December 2020) Authors: Walsh, Dana; Gonzalez, Carlos; Shannon, Bill; Blount, Ken Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗